Medical Properties Trust

MPTNYSEUSD

THESIS ALERT

Email me when the MPT thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$1.78
−$0.04 (−2.20%)Today 1M −42.04%
After hours$1.79+0.56%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$1.82
Prior regular-session close from the quote source.
$1.78–$1.86
Regular-session low and high so far today.
19.8M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 18 projected
Projected for 2027-02-18 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$1.72–$6.47
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own MPT if management stabilizes tenant credit and preserves long-term net-lease cashflows while it finishes balance-sheet repair.

MPT price history

Latest price$1.78Today−$0.04 (-2.20%)
MPT -43.76%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

4 MATERIAL PROPOSITIONS
  • Because most leases are long-term, triple-net with contractual minimum escalators (and CPI pass-throughs), MPT’s core rents should remain a relatively predictable cashflow stream that supports debt service and dividends unless multiple large operators default simultaneously.HoldingMateriality: High

    operating_cash_flow remained positive at 230,767,000 USD for FY 2025 (MD&A Selected Financial Data). If true, the business can generate stable FFO and service debt without asset fire-sales; if false, cashflows will be volatile and dividends at risk.

    Watch: a multi-property operator collapse (e.g., another Steward/Prospect/Vibra-sized default) that triggers re-tenating losses and large impairment charges.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    operating_cash_flow remained positive at 230,767,000 USD for FY 2025 (MD&A Selected Financial Data).

    Open source ↗
  • Improved cash on hand and completed 2025 refinancings materially reduce near-term liquidity risk, giving the company time to resolve tenant issues without distressed asset sales—provided revolver capacity is extended and no major covenant/default shock occurs.StrengtheningMateriality: High

    cash and cash equivalents increased to 540,859,000 USD at December 31, 2025 (from 332,335,000 USD at 2024 year-end). If liquidity and refinancing are durable, MPT can avoid forced property disposals and allow normalized FFO to recover; failure would force asset sales and deepen impairments.

    Watch: lenders decline to extend the revolving credit facility or demand additional covenants/collateral when the revolver comes up for extension.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    cash and cash equivalents increased to 540,859,000 USD at December 31, 2025 (from 332,335,000 USD at 2024 year-end).

    Open source ↗
  • Because a small number of large healthcare operators drive concentrated exposure, tenant-specific failures produce outsized impairment/earnings swings—so future earnings stability depends on materially lower operator credit risk or re‑underwriting of exposures.StrengtheningMateriality: Medium

    net loss swung from (2,408,287) thousand USD in 2024 to (275,937) thousand USD in 2025, driven by large impairment and fair value adjustments (MD&A Selected Financial Data). The investing case hinges on reducing the frequency/magnitude of tenant credit events; if concentration persists, GAAP earnings and book value will remain volatile and the dividend will be harder to rely upon.

    Watch: management executes large, permanent portfolio de-risking (e.g., sell high-risk assets to stronger operators) or secures equity/joint-venture capital to absorb operator distress.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    net loss swung from (2,408,287) thousand USD in 2024 to (275,937) thousand USD in 2025, driven by large impairment and.

    Open source ↗
  • Contractual minimum escalators plus CPI-linked increases should, in normal renewals, help preserve nominal revenue and offset inflation’s cost impact—protecting rent-roll even if same-property cash NOI growth is limited.HoldingMateriality: Medium

    revenue remained near ~972,022,000 USD in 2025 (vs 995,547,000 USD in 2024) despite heavy portfolio disruption, and MD&A states typical minimum escalators are 2% and CPI adjustments apply. If escalators operate as written, revenue and cash rents keep pace with inflation and support interest coverage; if re-leases are done at materially lower levels or escalators are renegotiated away, revenue protection disappears.

    Watch: when re‑tenanting occurs, new leases are executed at materially lower base rents or with waived escalators.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    revenue remained near ~972,022,000 USD in 2025 (vs 995,547,000 USD in 2024) despite heavy portfolio disruption, and MD&A states typical.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Because most leases are long-term, triple-net with contractual minimum escalators (and CPI pass-throughs), MPT’s core rents should remain a relatively predictable cashflow stream that supports debt service and dividends unless multiple large operators default simultaneously. If true, the business can generate stable FFO and service debt without asset fire-sales; if false, cashflows will be volatile and dividends at risk.

Improved cash on hand and completed 2025 refinancings materially reduce near-term liquidity risk, giving the company time to resolve tenant issues without distressed asset sales—provided revolver capacity is extended and no major covenant/default shock occurs. If liquidity and refinancing are durable, MPT can avoid forced property disposals and allow normalized FFO to recover; failure would force asset sales and deepen impairments.

Because a small number of large healthcare operators drive concentrated exposure, tenant-specific failures produce outsized impairment/earnings swings—so future earnings stability depends on materially lower operator credit risk or re‑underwriting of exposures. The investing case hinges on reducing the frequency/magnitude of tenant credit events; if concentration persists, GAAP earnings and book value will remain volatile and the dividend will be harder to rely upon.

Contractual minimum escalators plus CPI-linked increases should, in normal renewals, help preserve nominal revenue and offset inflation’s cost impact—protecting rent-roll even if same-property cash NOI growth is limited. If escalators operate as written, revenue and cash rents keep pace with inflation and support interest coverage; if re-leases are done at materially lower levels or escalators are renegotiated away, revenue protection disappears.

All standing thesis claims
Original report summary

management stabilizes tenant credit and preserves long-term net-lease cashflows while it finishes balance-sheet repair.

Evidence assessed Nov 12, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Medical Properties Trust

Where the evidence on Medical Properties Trust stands: Holding on the latest evidence (Nov 12, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.

Bull case: what the evidence supports

  • Because most leases are long-term, triple-net with contractual minimum escalators (and CPI pass-throughs), MPT’s core rents should remain a relatively predictable cashflow stream that supports debt service and dividends unless multiple large operators default simultaneously.

    sec.gov ↗

  • Improved cash on hand and completed 2025 refinancings materially reduce near-term liquidity risk, giving the company time to resolve tenant issues without distressed asset sales—provided revolver capacity is extended and no major covenant/default shock occurs.

    sec.gov ↗

  • Because a small number of large healthcare operators drive concentrated exposure, tenant-specific failures produce outsized impairment/earnings swings—so future earnings stability depends on materially lower operator credit risk or re‑underwriting of exposures.

    sec.gov ↗

  • Contractual minimum escalators plus CPI-linked increases should, in normal renewals, help preserve nominal revenue and offset inflation’s cost impact—protecting rent-roll even if same-property cash NOI growth is limited.

    sec.gov ↗

Bear case: what would count against it

  • a multi-property operator collapse (e.g., another Steward/Prospect/Vibra-sized default) that triggers re-tenating losses and large impairment charges.

    sec.gov ↗

  • lenders decline to extend the revolving credit facility or demand additional covenants/collateral when the revolver comes up for extension.

    sec.gov ↗

  • management executes large, permanent portfolio de-risking (e.g., sell high-risk assets to stronger operators) or secures equity/joint-venture capital to absorb operator distress.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Medical Properties Trust

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed Medical Properties Trust’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Medical Properties Trust filed an SEC 8-K on 2026-10-29: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Entered a material definitive agreement.

    Medical Properties Trust filed an SEC 8-K on 2026-08-10: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Medical Properties Trust filed an SEC 8-K on 2026-08-10: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • a multi-property operator collapse (e.g., another Steward/Prospect/Vibra-sized default) that triggers re-tenating losses and large impairment charges.
  • lenders decline to extend the revolving credit facility or demand additional covenants/collateral when the revolver comes up for extension.
  • management executes large, permanent portfolio de-risking (e.g., sell high-risk assets to stronger operators) or secures equity/joint-venture capital to absorb operator distress.
  • when re‑tenanting occurs, new leases are executed at materially lower base rents or with waived escalators.

MPT news

Loading headlines…

Financial statements

MPT income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

MPT: quick answers

When does Medical Properties Trust (MPT) report earnings next?
Medical Properties Trust's next results are projected for February 18, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 29, 2026. Earnings calendar
What is MPT's short interest?
As of October 30, 2026, 149M MPT shares were sold short, 24.9% of its shares outstanding, down 0.5% from the count before. At the stock's average daily volume that is 7.6 days to cover. FINRA publishes the count twice a month. MPT short interest history
Have members of Congress traded MPT?
Reports made public in the last 90 days disclose 3 trades in MPT by 1 filer: 0 purchases and 3 sales. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed MPT trade
Which well-known investors own MPT?
2 of the 37 well-known funds tracked here reported MPT shares in their latest 13F filings. By share of the fund's portfolio: Coatue Management (Philippe Laffont), 0.0%; Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios

MPT in well-known investors’ portfolios

2 of 37 funds reported MPT shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Philippe LaffontCoatue Management0.04%$20.9MNo changeQ2 2026
Ray DalioBridgewater Associates0.00%$412K−7.9%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.